Pimozide and amphetamine have opposing effects on the reward summation function

https://doi.org/10.1016/0091-3057(84)90104-7Get rights and content

Abstract

The reward summation function is the plot of self-stimulation performance as a function of the number of pulses in a train of fixed duration. It has previously been shown that drugs that impair performance compress this curve but do not shift it laterally; whereas when the reinforcing efficacy is reduced by reducing current intensity, the curve shifts laterally. The amount of the shift is a measure of the magnitude of a drug's effect upon reinforcing efficacy. We report here that pimozide shifts the curve to the right in a dose-dependent manner, indicating an impairment of reinforcing efficacy, while amphetamine shifts it to the left, indicating an enhancement of reinforcing efficacy. When the two drugs are given together their effects on the reward summation function cancel out. These results are consistent with the hypothesis that pimozide and amphetamine exert their effects on reinforcing efficacy via one and the same set of dopaminergic synapses.

References (11)

There are more references available in the full text version of this article.

Cited by (139)

  • Enhanced perceptual task performance without deprivation in mice using medial forebrain bundle stimulation

    2022, Cell Reports Methods
    Citation Excerpt :

    Therefore, for the majority of studies focused on sensory or motor behaviors and not motivation or reward per se, MFB stimulation is unlikely to modify the results of interest and provides a way to avoid the side effects of deprived states. MFB stimulation evokes dopamine release in the NA28 and pharmacologically increasing or reducing dopamine levels increases or reduces MFB stimulation efficacy respectively.29 Although the MFB contains dopaminergic fibers essential for instrumental behavior,30 it has been shown that the physiology of MFB self-stimulation is incompatible with a direct recruitment of these fibers to drive reward.31

  • Dual roles of dopamine in food and drug seeking: The drive-reward paradox

    2013, Biological Psychiatry
    Citation Excerpt :

    Similarly, both are facilitated by delta-9 tetrahydrocannabinol (57–59). While amphetamine is an anorexigenic drug, even it potentiates aspects of stimulation-induced feeding (60), as well as brain stimulation reward (61), particularly when it is microinjected into nucleus accumbens (62,63). How do the first-stage fibers of brain stimulation reward interact with the dopamine system?

  • Concurrent stimulation-induced place preference in lateral hypothalamus and parabrachial complex: Differential effects of naloxone

    2011, Behavioural Brain Research
    Citation Excerpt :

    In this context, recent studies in our laboratory indicated the likely involvement of the endogenous opioid system in the reward induced by electrical stimulation of the LPBe [25]. Intracranial self-stimulation (ICSS) behavior induced in the MFB has been related to dopaminergic ([6], for a review [23,41–46]) and opioid systems [41,47]. With regard to the opioid system, controversial results have been obtained by studies using antagonists such as naloxone in operant tasks ([47], for a review [48–50]).

View all citing articles on Scopus
View full text